Primary mammary angiosarcomas harbor frequent mutations in KDR and PIK3CA and show evidence of distinct pathogenesis-Reference-Cited by-同舟云学术

Primary mammary angiosarcomas harbor frequent mutations in KDR and PIK3CA and show evidence of distinct pathogenesis

Published:2020-03-02 Issue:8 Volume:33 Page:1518-1526
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Mod Pathol

Author:

Beca Francisco^ORCID,Krings Gregor,Chen Yunn-Yi,Hosfield Elizabeth M.,Vohra Poonam,Sibley Richard K.,Troxell Megan L.,West Robert B.,Allison Kimberly H.,Bean Gregory R.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

http://www.nature.com/articles/s41379-020-0511-6.pdf

Reference78 articles.

1. Young RJ, Brown NJ, Reed MW, Hughes D, Woll PJ. Angiosarcoma. Lancet Oncol. 2010;11:983–91.

2. Fayette J, Martin E, Piperno-Neumann S, Le Cesne A, Robert C, Bonvalot S, et al. Angiosarcomas, a heterogeneous group of sarcomas with specific behavior depending on primary site: a retrospective study of 161 cases. Ann Oncol. 2007;18:2030–6.

3. Naka N, Ohsawa M, Tomita Y, Kanno H, Uchida A, Myoui A, et al. Prognostic factors in angiosarcoma: a multivariate analysis of 55 cases. J Surg Oncol. 1996;61:170–6.

4. Mark RJ, Poen JC, Tran LM, Fu YS, Juillard GF. Angiosarcoma. A report of 67 patients and a review of the literature. Cancer. 1996;77:2400–6.

5. Lahat G, Dhuka AR, Hallevi H, Xiao L, Zou C, Smith KD, et al. Angiosarcoma: clinical and molecular insights. Ann Surg. 2010;251:1098–106.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hemangiosarcoma Cells Promote Conserved Host-derived Hematopoietic Expansion;Cancer Research Communications;2024-06-11

2. Mesenchymal Lesions;Tumors of the Mammary Gland;2024-01

3. Mesenchymal Neoplasms of the Liver;Surgical Pathology Clinics;2023-09

4. Contemporary diagnostic approach to atypical vascular lesion and angiosarcoma;Seminars in Diagnostic Pathology;2023-07

5. New molecular targets in canine hemangiosarcoma—Comparative review and future of the precision medicine;Veterinary and Comparative Oncology;2023-06-12